Drugs / Comparator 1
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT07851246 Comparator | Oct 2026 → Jul 2027 expected | influenza | GlaxoSmithKline | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Comparator 1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07851246 ↗ |
| Modality | Vaccine | “One dose of the comparator vaccine received intramuscularly.” NCT07851246 ↗ |
| Route | Intramuscular | “received intramuscularly” NCT07851246 ↗ |